The conduction and cardiac sympathetic systems: Metabolic aspects  by Kübler, Wolfgang et al.
JACCVol. 5, No.6
June 1985:157B-16IB
MYOCARDIAL METABOLISM
Michael F. Oliver, MD, FACC, Moderator
1578
The Conduction and Cardiac Sympathetic Systems: Metabolic Aspects
WOLFGANG KUBLER, MD, FACC, ALBERT SCHOMIG, MD, JOCHEN SENGES, MD
Heidelberg, West Germany
Compared with the myocardium, glycolytic enzymesare
reduced by 50% and mitochondrial enzymes and space
by 70% in the conduction system of the calf heart. In
• addition, on the basis of adenosine triphosphate activities
energy demands are reduced by more than 50%; this is
in parallel with the reduction in myofibrillar space. The
increased tolerance of the conduction system against
ischemia can be explained by a reduction of energy de-
mands and a higher proportion of (anaerobic) glycolytic
as opposed to aerobic mitochondrial energy production.
Among the structures of the conduction system, the si-
noatrial and atrioventricular nodes are markedly sus-
ceptible to hypoxia in contrast to atrial conduction and
ventricular conductionby wayof the His-Purkinje system.
In most patients, sudden cardiac death is caused by ven-
tricular tachyarrhythmias that are based on inhomogeneity
of excitable cardiac tissue, the most common cause being
ischemia. This inhomogeneity can be attributed to different
phases of ischemic damage either of the myocardium or the
conduction system, or both. Furthermore, the metabolic
changes may be modulated by local factors such as sym-
pathetic discharge. The changes occurring in the energy
metabolism of the working myocardium during ischemia
have been discussed previously (I). Little information, how-
ever, is available regarding the metabolic changes of other
cardiac structures such as the conduction and the sympa-
thoneuronal system.
Conduction System
Energy production and demands. After staining with
fluorescein, the right and left main bundle of His of the calf
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In the isolated perfused rat heart, an increased net
release of noradrenaline during the first 10 minutes of
ischemia is only noted after sympathetic stimulation.
During this phase, catecholamine overflow is limited by
the activity of the neuronal reuptake. At a later second
phase, from 15 to 40 minutes after the onset of ischemia,
the mechanism of noradrenaline net release is carrier-
mediated efflux inhibited by neuronal uptake blocking
agents. During the third phase of ischemia, after about
40 minutes, spontaneous noradrenaline release is greatly
augmented, probably as a result of leakage caused by
membrane damage.
(J Am CoU CardioI1985;5:157B-161B)
heart can be visualized in the ultraviolet light and then easily
isolated (2). By determination of enzyme activities in ho-
mogenates of myocardium and of the conduction system,
energy metabolism has been evaluated (2). In addition, with
the use of light microscopic and electron microscopic tech-
niques, the myofibrillar and mitochondrial space in the His-
Purkinje system and myocardium has been determined mor-
phometrically (3).
Glycolytic energy production. In Figure 1, enzyme dis-
tribution patterns are shown for glycolytic and other cyto-
plasmic enzymes. Glycolytic enzymes are present in the
conduction system in only about half the activity as com-
pared with the myocardium. Because glycolytic flux de-
pends on the instantaneous activities of regulatory enzymes,
glycolytic flux is reduced in the conduction system to the
same extent.
Mitochondrial energy production. Aerobic mitochon-
drial energy production is also reduced in the conduction
system (to about 30%). This also applies to the mitochon-
drial activity of bilocular enzymes. The contents of cyto-
chromes (Cyt a and Cyt c) and mitochondrial space are
likewise greatly reduced in the conduction system (Fig. 2).
Because mitochondrial space, mitochondrial enzyme activ-
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calcium- and magnesium-induced adenosine triphosphate
(ATP) lysis are reduced in the conduction system by more
than 50%. In addition, myofibrillar space is reduced
(Fig. 3).
The following conclusions may be made: I) energy pro-
duction in the conduction system is reduced; 2) energy de-
mands are also reduced; and 3) the ratio of anaerobic gly-
colytic to aerobic mitochondrial metabolism favors glycolysis
in the conduction system. The metabolic data explain that
the conduction system can tolerate a longer period of isch-
emia than can the myocardium (5) because of a higher
proportion of glycolysis on total energy production and a
decrease in energy demands.
The SA and AV nodes. To study metabolic character-
isticsof the sinoatrial (SA) and atrioventricular(AV) nodes,
the effects of severe hypoxia and inhibitors of glycolysis
were investigated in the isolated superperfused preparation
of the rabbit heart (6) and a right ventricularpreparation of
thecanine heart (7). Whereassinus rateand AVconduction,
both dependent on slow inward current, are markedly de-
creasedunderhypoxicconditions, atrialand ventricularcon-
duction by way of the His-Purkinje system are virtually
unchanged. In all hypoxic experiments, the addition of jo-
doacetate or desoxyglucose, or both, to block glycolysis
results in sinus arrest and atrial and AV nodal conduction
block (Fig. 4). Under aerobic conditions, however, inhi-
bitionof glycolysisproducednone of these effects. The data
reveal marked differences in susceptibility to hypoxia of
different structures of the condition system.
Sympathoneuronal System
The occurrenceof myocardial necrosis(8) and ventricular
tachyarrhythmias (9), has been related to high local con-
centrations of noraderenaline during ischemia. The positive
results of secondary prevention beta-blocking trials after
myocardial infarction may support this concept. Cardiac
catecholamine release during ischemia was, therefore, in-
vestigated in the isolated perfusedrat heart preparation (10).
Catecholamine release during ischemia. Withoutsym-
patheticstimulation, no increasein net noradrenaline release
can be detected in periods of ischemia ranging up to 10
minutes. After prolongation of the ischemic period beyond
10 minutes, increasing amounts of noradrenaline are re-
leased. After 60 minutes of ischemia, the cardiac cate-
cholamine stores are almost depleted. The amount of nor-
adrenaline in the venous effluent during reperfusion, in
principle, decreases with time, indicatinga simple washout
process (10). This is also the case for adrenaline and deam-
inated metabolites such as 3,4 dihydroxy-phenyl-ethylen-
glycol.
Effect of an inhibitor of neuronal reuptake.
Catecholamine net release was further investigated after
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rues and the amount of cytochromes are reduced in the
conduction system to the same extent, the contents of cy-
tochromesand enzymesper volumemitochondria are almost
identical in the conduction system and myocardium.
Energy demands. In the conduction system, energy de-
mands are also reduced. Specific potassium-sodium-
adenosine triphosphatase (ATPase) activity as well as
Figure1. Distribution pattern ofcytoplasmic enzymes inthecon-
duction system and the myocardium of the calf's heart. AK =
adenylate kinase (2.7.4.3.); ALD = fructose-Lti-diphosphate-al-
dolase (4.1.2.b);CK = creatine kinase (2.7.3.2.); EN = enolase
(4.2.I.ll.); F6PK = fructose-o-phosphate-kinase = phospho-
fructo-kinase (2.7.l.ll.); GAPDH = glyceraldehydephosphate-
dehydrogenase (1.2.1.12.); GDH = L-glycerol-3-phosphate: NAD
oxidoreductase = glycerine-I-phosphate-dehydrogenase (1. 1.18.);
GPM = phosphoglyceromutase (2.7.5.3.); HBDH = alpha-hy-
droxybutyratedehydrogenase = LDH-isoenzyme I; HK = hexo-
kinase (2.7.1.1.); HPI = glucosephosphate-isomerase (5.3.1.9.);
LDH = lactic dehydrogenase (1.1.1.28.); ME = malate dehy-
drogenase (decarboxylating) = malic enzyme (1.1.1.40. );
PGK = phosphoglycerate kinase (2.7.2.3.); PGLUM = phos-
phogluco-mutase (2.7.5.1.);Phos = phosphorylase a + b(2.4.1 .1.);
PK = pyruvate kinase (2.7.1.40.); TIM = triosephosphate iso-
merase (5.3.1 .1.). Numbers in parenthesesindicate classifications
according to enzyme commission's numbering system.
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Figure 2. Aerobic energy production . Activities of
mitochondrial enzymes of cytochrome (cyt) con-
tents arid of mitochondrial space in the conduction
system (CT) expressed as percent (%) of the value
obtained in the left ventricular (LV) myocardium.
CE = condensing enzyme = citrate synthase
(4.1.3 .7.); FUM = fumarase (4.2.1.2 .); HOAD =
beta-hydroxy-acyl-CoA-dyhydrogenase (1.1.1.35.);
m = mitochondrial activity of bilocular enzymes;
m-IDH = mitochondrial isocitrate-dehydrogenase
(1.1.1.42.) = mitochondrial aspartate-aminotrans-
ferase (2.6.1.1.); m-MDH = mitochondrial malate-
dehydrogenase (1.1.1.37.) Numbers in parentheses
indicate classification according to enzyme com-
mission's numbering system.
different phases of ischemia with and without desipramine ,
an inhibitor of neuronal reuptake, the main inactivation pro-
cess for catecholamines. Under aerobic control conditions
and at the beginning of ischemia , net catecholamine release
was either increased or unaffected by the administration of
desipramine . After more than 10 minutes of ischemia, how-
ever , desipramine reduced cardiac catecholamine release ,
whereas after 60 mintues it had no effect on cardiac nora-
drenaline release (Fig . 5) . Similar results were obtained with
cocaine, another inhibitor of neuronal uptake (11).
Effect of sympathetic stimulation on catecholamine
release. To test the effect of sympathetic stimulation on
cardiac catecholamine release, the left stellate ganglion was
electrically stimulated (12) during an aerobic control period
and during a I minute ischemic period . Under these con-
ditions, net cardiac catecholamine release was greatly re-
duced in the ischemic experiments owing to noncontinuous
washout and, hence, increased neuronal reuptake. Inhibition
of neuronal uptake by desipramine, therefore, greatly in-
creased catecholamine net discharge. especially under isch-
emic conditions. By extending the ischemic period to 10
minutes , however, this effect of desipramine (increased net
catecholamine release) was markedly attenuated . During an
ischemic period of 20 minutes, addition of desipramine even
further reduced net catecholamine release; this was true in
experiments with and without sympathetic stimulation.
Under aerobic conditions, the neuronal uptake blocking
agent. desipramine, greatly increased noradrenaline release;
the same was true for yohimbine, a presynaptic alpha .-
blocking agent. The local anesthetic lidocaine, however ,
greatly reduced catecholamine release under aerobic con-
ditions, indicating exocytosis of the neurotransmitter. After
20 minutes of ischemia, other mechanisms were operating.
Neither yohimbine nor lidocaine affected catecholamine re-
lease, whereas the neuronal uptake blocking agent, desi-
pramine, now greatly reduced noradrenaline release.
Summary of data. During phase 1 ofmyocardial isch-
emia , lasting for approximately 10 minutes under the ex-
perimental conditions, spontaneous release of noradrenaline
is unaltered compared with aerobic control conditions. How-
ever , it is increased by sympathetic stimulation. Because
neuronal uptake is still active during phase i, its inhibition
by neuronal uptake and alpha--blocking agents augments
noradrenaline release. On the other hand, local anesthetics
greatly inhibit noradrenaline release during this phase.
Therefore. the predominant mechanism of noradrenaline re-
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Figure 3. Energy consumption. Sodium (Na + )-po-
tassium (K + )-adenosine triphosphatase (A'I'Pase)
activity, calcium (Ca+ +)- and magnesium (Mg + +)-
induced adenosine triphosphate (ATP) lysis and
myotibrillar space in the conduction system (CT)
expressed as percent (%) of the value obtained in
the left ventricular (LV) myocardium .
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Figure 4. Effect of hypoxia and inhibition of gly-
colysis on function of conduction system. Sino-
atrial (SA) node activity and atrial and atrioven-
tricular (AV) nodal and ventricular conduction by
way of the His-Purkinje (H-P) system under nor-
motoxic and hypoxic conditions with and without
inhibition of glycolysis with desoxyglucose. The
data are given as percent of the value obtained
under norrnotoxic control conditions. *p < 0.05 .
Conduction
velocity
50
a
o
50
100
[%]
Conduction
velocity
•~
AV-node
•
'-----'Atrium
50
a
o
50
Sinus
rate
100
[%]
Sinus
rate
SA-node Atrium AV-node
r...... of nor8drenellne
2000
prnol/g
200
20
2
control
period
ITilll p.rfualon with d.alpr.mlne 100 nm
Figure 5. Cardiac noradrenaline release dur-
ing different phases of ischemia with and
without desipramine .
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lease during early ischemia can be assumed to be exocytosis
similar to that under aerobic control conditions.
During phase 2, lasting for about 15 to 40 minutes of
ischemia, spontaneous noradrenaline release is augmented,
probably because of impaired neuronal uptake. Under these
conditions, net catecholamine release is not affected by sym-
pathetic stimulation. Inhibition of neuronal uptake, how-
ever, results in a marked decrease in noradrenaline release.
This indicates that the predominant mechanism of nor-
adrenaline release is carrier-mediated efflux.
During phase 3, an ischemic period of at least 40 min-
utes, spontaneous noradrenaline release is greatly aug-
mented. It is not influenced by neuronal uptake blocking
agents; therefore, leakage caused by membrane damage can
be assumed to be the predominant release process.
Conclusions. Metabolic inhomogeneity of cardiac tissue
during ischemia can be attributed, apart from focal damage
of myocardium, to differences in energy metabolism of the
conduction system. Ischemic damage and electrical abnor-
malities are further modulated by local sympathetic activity,
which in the ischemic heart is mainly determined by local
factors such as catecholamine release and inactivation
processes.
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